Publications by authors named "F M Consolim-Colombo"

Introduction: Telemedicine, propelled by recent technological advancements, has transformed healthcare delivery, notably benefiting patients with chronic non-communicable diseases (NCDs) such as systemic arterial hypertension and diabetes mellitus. This meta-analysis of randomized clinical trials aimed to assess the efficacy of telehealth-based interventions on disease control rates and clinical parameters among NCD patients, including systolic and diastolic blood pressure (SBP and DBP), fasting blood glucose (FBG), and glycated hemoglobin (HbA1c) levels.

Methods: We conducted searches in PubMed, Scopus, Web of Science, and the Cochrane Database for interventional studies that compared tele-monitoring with usual care in patients with hypertension and type 2 diabetes mellitus.

View Article and Find Full Text PDF

Introduction: The long-term efficacy of renal denervation (RDN) has not been extensively documented.

Aim: To describe the long-term follow-up of patients after RDN.

Methods: We evaluated patients with resistant hypertension (RH) who underwent RDN with irrigated catheter from 2012 to 2014 at a single centre.

View Article and Find Full Text PDF

Background: Atherosclerotic cardiovascular disease (ASCVD), affects approximately 18.6 million individuals worldwide and poses a significant healthcare related challenge. Despite the established efficacy of both high-intensity statin monotherapy (HIS) and moderate-intensity statin plus ezetimibe (MIS+EZT) in ASCVD management, the optimal treatment strategy remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Resistant arterial hypertension (RAH) is a significant global health issue linked to increased cardiovascular risk, and the effectiveness of ultrasound renal denervation (uRDN) as a treatment is not fully understood.
  • This study analyzed data from five trials involving 709 patients to evaluate the impact of uRDN on reducing both systolic and diastolic blood pressure in those with RAH.
  • Results indicated that uRDN significantly lowered office blood pressure levels compared to sham treatments, though more research is necessary to fully assess its efficacy in managing RAH.
View Article and Find Full Text PDF